PLUS THERAPEUTICS, INC. financial data

Symbol
PSTV on Nasdaq
Location
Austin, TX
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 121% % 183%
Debt-to-equity -597% % -178%
Return On Equity 775% % 297%
Return On Assets -156% % 8.5%
Operating Margin -293% % -16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 171,550,698 shares 909%
Common Stock, Shares, Outstanding 138,675,856 shares 2252%
Entity Public Float $31,900,000 USD 289%
Common Stock, Value, Issued $139,000 USD 2217%
Weighted Average Number of Shares Outstanding, Basic 77,804,612 shares 1072%
Weighted Average Number of Shares Outstanding, Diluted 77,804,612 shares 910%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $5,213,000 USD -10%
Research and Development Expense $8,379,000 USD -21%
General and Administrative Expense $12,132,000 USD 22%
Operating Income (Loss) $15,298,000 USD -4.1%
Nonoperating Income (Expense) $7,088,000 USD -513%
Net Income (Loss) Attributable to Parent $22,386,000 USD -72%
Earnings Per Share, Basic -0.29 USD/shares 85%
Earnings Per Share, Diluted -0.29 USD/shares 88%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,256,000 USD 5500%
Cash, Cash Equivalents, and Short-term Investments $13,100,000 USD
Other Assets, Current $1,734,000 USD 60%
Assets, Current $15,170,000 USD 188%
Property, Plant and Equipment, Net $257,000 USD -43%
Operating Lease, Right-of-Use Asset $70,000 USD -4.1%
Goodwill $372,000 USD 0%
Other Assets, Noncurrent $123,000 USD 925%
Assets $16,325,000 USD 146%
Accounts Payable, Current $3,276,000 USD -65%
Liabilities, Current $12,314,000 USD -21%
Operating Lease, Liability, Noncurrent $15,000 USD -52%
Liabilities $12,329,000 USD -21%
Retained Earnings (Accumulated Deficit) $515,865,000 USD -4.5%
Stockholders' Equity Attributable to Parent $3,996,000 USD
Liabilities and Equity $16,325,000 USD 146%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,172,000 USD -37%
Net Cash Provided by (Used in) Financing Activities $12,405,000 USD
Net Cash Provided by (Used in) Investing Activities $3,558,000 USD
Common Stock, Shares Authorized 2,000,000,000 shares 1900%
Common Stock, Shares, Issued 138,934,281 shares 2157%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,791,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $23,000 USD -68%
Deferred Tax Assets, Valuation Allowance $25,910,000 USD 15%
Deferred Tax Assets, Gross $25,925,000 USD 15%
Operating Lease, Liability $71,000 USD -5.3%
Payments to Acquire Property, Plant, and Equipment $3,000 USD -92%
Lessee, Operating Lease, Liability, to be Paid $77,000 USD -3.8%
Property, Plant and Equipment, Gross $3,592,000 USD 0.11%
Operating Lease, Liability, Current $56,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,000 USD 36%
Lessee, Operating Lease, Liability, to be Paid, Year One $62,000 USD -10%
Operating Lease, Weighted Average Discount Rate, Percent 0.127 pure 9.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,000 USD 20%
Deferred Tax Assets, Operating Loss Carryforwards $19,275,000 USD 25%
Preferred Stock, Shares Issued 1,952 shares 0%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $557,000 USD 31%
Operating Lease, Payments $58,745 USD
Additional Paid in Capital $520,222,000 USD 7.3%
Preferred Stock, Shares Outstanding 1,952 shares 0%
Depreciation, Depletion and Amortization $146,000 USD -5.8%
Deferred Tax Assets, Net of Valuation Allowance $15,000 USD 0%
Interest Expense $210,000 USD -64%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%